• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

MMA Payout

The Business of Combat Sports

  • Home
  • MMA
    • UFC
    • Bellator
    • One
    • PFL
  • Boxing
  • Legal
  • Ratings
  • Payouts
  • Attendance
  • Gate

CSAC revokes Jon Jones’ fight license and fines him $205,000 for failed drug test

February 27, 2018 by Jason Cruz Leave a Comment

The California State Athletic Commission unanimously voted (6-0) to revoke Jon Jones’ fight license and invoke a $205,000 fine against him for a banned steroid in his system discovered in a pre-fight drug test at UFC 214.

The $205,000 fine is 40% of his $500,000 disclosed pay (plus $5,000) for his matchup with Daniel Cormier at UFC 214 on July 29th.

At a hearing held on Tuesday morning, the California State Athletic Commission heard Jones’ testimony as well as those from two experts that opined on Jones’ test results and how he could have had Turanibol and its metabolites in Jones’ system.  Jones did not dispute the finding but seemed to rest his case on the fact that he did not knowingly take the substance.  Jones did not appear to be a very good witness advocating on his own behalf.

Notably, Dr. Daniel Eichner stated that he has never heard of an case where a medication, supplement or otherwise to have been tainted with Turanibol or its metabolites.

Jones may re-apply for a CSAC license at the conclusion of his case with USADA.  Jones will need to make a request before the CSAC and receive a majority vote.  His license revocation was set to expire on August 28th per ESPN.com’s Brett Okamoto.

USADA has yet to rule on Jones’ case although his representatives believe it could happen as soon as next month.  According to the UFC Anti-Doping Policy, Jones, a potential second-time offender, could be facing a 4-year ban.

Typically, other states would honor California’s license revocation, so any thought that Jones could fight in another state is unlikely.

Payout Perspective:

The prospects of Jones in a UFC octagon in 2018 looks bleak.  While, the CSAC did not issue a longer suspension, it appears that they are awaiting USADA to do the duty.  Jones’ admission to the test findings likely seals his fate.  The strategy of arguing that Jones did not knowingly take Turinabol but offering no other reason for the test had no effect in mitigating the penalties.  I would not expect USADA to mitigate any penalty either but we shall see.

Filed Under: CSAC, Drug Testing, regulation, UFC

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Featured

UFC 330 Payout Perspective

Update on CSI Entertainment – Mayweather lawsuit, Injunction request withdrawn

The Legal Submission 109 takes a look at TKO Earnings

Plaintiffs in Johnson antitrust lawsuit file statement prior to status conference

Despite two big losses, TKO touts another solid quarter

Muhammad Ali American Boxing Revival Act of 2026 introduced into Senate with minor changes

Archives

MMA Payout Follow

MMAPayout

😂🤣😂

Dan Canobbio @DanCanobbio

The Money Team Law Firm

Retweet on Twitter MMA Payout Retweeted

#Zuffa filed its Reply Brief in its appeal to the 9th Circuit in the Cirkunov antitrust lawsuit. Appeal is based on district court's decision to determine whether defendants held monopoly/monopsony power and whether the contract clauses were unsconsionable #UFC

2

The mysterious $11M man or woman #UFC https://mmapayout.com/2026/08/26/the-mysterious-11m-man-or-woman/

Retweet on Twitter MMA Payout Retweeted

Thank you Seattle for the privilege. How often can anyone buy a Super Bowl winning team? Humbled.

Load More

Copyright © 2026 · MMA Payout: The Business of Combat Sports